Hallie Carol

ORCID: 0000-0001-8890-9785
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Epigenetics and DNA Methylation
  • Genetic Associations and Epidemiology
  • Autoimmune and Inflammatory Disorders Research
  • Cancer Genomics and Diagnostics
  • Renal and related cancers
  • Telomeres, Telomerase, and Senescence
  • Immunodeficiency and Autoimmune Disorders
  • Inflammatory Myopathies and Dermatomyositis
  • Dietary Effects on Health
  • Eosinophilic Disorders and Syndromes
  • Health, Environment, Cognitive Aging
  • Genetics, Aging, and Longevity in Model Organisms
  • Cancer therapeutics and mechanisms
  • Genomics and Phylogenetic Studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Hematological disorders and diagnostics
  • Seaweed-derived Bioactive Compounds
  • Synthesis and pharmacology of benzodiazepine derivatives
  • Microbial Inactivation Methods
  • Spondyloarthritis Studies and Treatments
  • Cytomegalovirus and herpesvirus research
  • Bee Products Chemical Analysis
  • Glycosylation and Glycoproteins Research
  • Biochemical and Molecular Research

Children's Hospital of Philadelphia
2023-2025

University of Pennsylvania
2025

Lurie Children's Hospital
2022

Northwestern University
2022

Bowdoin College
2020

Dana-Farber Cancer Institute
2016-2019

Harvard University
2019

Cedars-Sinai Medical Center
2019

Harvard University Press
2017

University of Washington
2011

Mattias Johansson Robert Carreras‐Torres Ghislaine Scélo Mark P. Purdue Daniela Mariosa and 95 more David C. Muller Nicholas J. Timpson Philip Haycock Kevin M. Brown Zhaoming Wang Yuanqing Ye Jonathan N. Hofmann Matthieu Foll Valérie Gaborieau Mitchell J. Machiela Leandro M. Colli Peng Li Jean-Guillaume Garnier Hélène Blanché Anne Boland Laurie Burdette Egor Prokhortchouk K. G. Skryabin Meredith Yeager Sanja Radojević-Škodrić Simona Ognjanovic Lenka Foretová Ivana Holcátová Vladimí­r Janout Dana Mateș Anush Mukeriya Ștefan Rașcu Давид Заридзе Vladimír Bencko Cezary Cybulski Eleonóra Fabiánová Viorel Jinga Jolanta Lissowska Jan Lubiński Marie Navrátilová Péter Rudnai Simone Benhamou Géraldine Cancel‐Tassin Olivier Cussenot Elisabete Weiderpass Börje Ljungberg Raviprakash T. Sitaram Christel Häggström Fiona Bruinsma Susan J. Jordan Gianluca Severi Ingrid Winship Kristian Hveem Lars J. Vatten Tony Fletcher Susanna C. Larsson Alicja Wolk Rosamonde E. Banks Peter J. Selby Douglas F. Easton Gabriella Andreotti Laura E. Beane Freeman Stella Koutros Satu Männistö Stephanie J. Weinstein Peter E. Clark Todd L. Edwards Loren Lipworth Susan M. Gapstur Victoria L. Stevens Hallie Carol Matthew L. Freedman Mark M. Pomerantz Eunyoung Cho Kathryn M. Wilson J. Michael Gaziano Howard D. Sesso Neal D. Freedman Alexander S. Parker Jeanette E. Eckel‐Passow Wen‐Yi Huang Richard J. Kahnoski Brian R. Lane Sabrina L. Noyes David Petillo Bin Tean Teh Ulrike Peters Emily White Garnet L. Anderson Lisa Johnson Juhua Luo Julie E. Buring I‐Min Lee Wong‐Ho Chow Lee E. Moore Timothy Eisen Marc Henrion James Larkin Poulami Barman Bradley C. Leibovich

Background Several obesity-related factors have been associated with renal cell carcinoma (RCC), but it is unclear which individual directly influence risk. We addressed this question using genetic markers as proxies for putative risk and evaluated their relation to RCC in a mendelian randomization (MR) framework. This methodology limits bias due confounding not affected by reverse causation. Methods findings Genetic obesity measures, blood pressure, lipids, type 2 diabetes, insulin, glucose...

10.1371/journal.pmed.1002724 article EN public-domain PLoS Medicine 2019-01-03

ABSTRACT This single‐institution retrospective cohort study evaluates the risk of thromboembolic events (TE) in patients with juvenile dermatomyositis (JDM) treated intravenous immunoglobulin (IVIg). We found no difference occurrence TE JDM IVIg as compared to those without exposure; both cohorts had TEs. Patients matched levels other clotting factors, such periods limited mobility and hormonal contraceptive use. research supports growing body evidence adult DM population demonstrating...

10.1111/pde.15865 article EN cc-by-nc Pediatric Dermatology 2025-01-09

High ferritin is an important and sensitive biomarker for the diverse deadly group of cytokine storm syndromes grouped together under term hemophagocytic lymphohistiocytosis. Early identification syndrome its contributors are critical to guiding targeted treatments preventing immunopathology, morbidity, mortality. Unfortunately, we lack specific diagnostic biomarkers, which complicates etiologic workup delays intervention. Through implementing a hyperferritinemia alert system, hoped identify...

10.70962/cis2025abstract.47 article EN cc-by 2025-04-25

Bacterial cell surface glycans are quintessential drug targets due to their critical role in colonization of the host, pathogen survival, and immune evasion. The dense envelope glycocalyx contains distinctive monosaccharides that stitched together into higher order yield exclusively bacterial structures for strain fitness pathogenesis. However, systematic study inhibition glycosylation enzymes remains challenging. Bacteria produce containing rare sugars refractory traditional glycan...

10.1021/acsinfecdis.0c00612 article EN ACS Infectious Diseases 2020-11-13

Determining the function of non-coding regulatory variants in cancer is a key challenge transcriptional biology. We investigated genetic (germline and somatic) determinants mechanisms renal cell carcinoma (RCC) using H3K27ac ChIP-seq data 10 matched tumor/normal samples RNA-seq from 496/66 The Cancer Genome Atlas (TCGA). Unsupervised clustering activity cleanly separated tumor normal individuals, highlighting extensive epigenetic reprogramming during transformation. developed novel method to...

10.1101/631150 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2019-05-08

Abstract High ferritin is an important and sensitive biomarker for the various forms of hemophagocytic lymphohistiocytosis (HLH), a diverse deadly group cytokine storm syndromes. Early action to prevent immunopathology in HLH often includes empiric immunomodulation, which can complicate etiologic work-up collection early/pre-treatment research samples. To address this, we instituted alert system at UPMC Children’s Hospital where serum > 1000 ng/mL triggered real-time chart review,...

10.1007/s10875-024-01797-4 article EN cc-by Journal of Clinical Immunology 2024-09-12

Tocilizumab is reported to reduce systemic inflammation in individuals with SLC29A3 spectrum disorder, but its effect on hearing loss has not been described. The authors present a boy toddler history of prematurity, dysphagia, hypersplenism, hyperpigmentation, short height and who was referred the immunology clinic. He initially presented shortly after birth abnormal screens followed by positive urine test for cytomegalovirus. However, infection determined be postnatally acquired most likely...

10.1136/bcr-2022-249191 article EN BMJ Case Reports 2022-06-01

<title>Abstract</title> High ferritin is an important and sensitive biomarker for hemophagocytic lymphohistiocytosis (HLH), a diverse deadly group of cytokine storm syndromes. Early action to prevent immunopathology in HLH often includes empiric immunomodulation, which can complicate etiologic work-up collection early/pre-treatment research samples. To address this, we instituted alert system where serum &gt; 1000ng/mL triggered real-time chart review, assessment whether the value reflected...

10.21203/rs.3.rs-4523502/v1 preprint EN cc-by Research Square (Research Square) 2024-06-25
Coming Soon ...